Royalty Pharma Plc (RPRX)
48.57
+0.08
(+0.16%)
USD |
NASDAQ |
Apr 02, 16:00
48.56
-0.01
(-0.02%)
After-Hours: 20:00
Royalty Pharma Research and Development Expense (TTM) : 452.50M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Zymeworks, Inc. | 137.00M |
| PTC Therapeutics, Inc. | 455.25M |
| Johnson & Johnson | 14.72B |
| Revolution Medicines, Inc. | 978.68M |
| Cytokinetics, Inc. | 405.90M |